A case report of malignant eccrine spiradenoma and review of the literature

Xiaofang He,Jing Hu,Mi Yang,Li Li,Qi Sun,Baorui Liu,Xiaoping Qian

DOI: https://doi.org/10.3969/j.issn.1672-4992.2017.08.036

2017-01-01

Journal of Modern Oncology

Abstract:Objective:To explore the diagnosis and treatment of malignant eccrine spiradenoma.Methods:We reported a case of malignant eccrine spiradenoma,and reviewed literature about the diagnosis and treatment of malignant eccrine spiradenoma.Results:We reported a case of a 67-year-old woman,who found an enlarging nodule in her right lower limb and underwent surgical resection of the mass in June 2015,the postoperative pathology showed malignant eccrine spiradenoma.After local resection,multiple metastases to the right iliac artery and right inguinal lymph nodes were confirmed by postoperative positron emission tomography/computed tomography of the whole body.She agreed to a trial of chemotherapy of "mFOLFOX",but the patient had a tumor recurrence and did operation twice.After surgery,the patient did not have antitumor therapy due to physically weakness.She was given the best symptomatic and supportive treatment and died on July 21st,2016.Conclusion:The clinical manifestation of MES lacks the specificity,and MES should be confirmed by pathology,the first choice for treatment of MES is complete resection covering enough tumor-free margins.There is still no generally accepted chemoradiotherapy,the prognosis of MES is poor and it has short survival time.